相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
Erica Dahl Warlick et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation
Ya-Yuan Fu et al.
IMMUNITY (2019)
T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage
S. Takashima et al.
SCIENCE IMMUNOLOGY (2019)
IL-2 Enhances Gut Homing Potential of Human Naive Regulatory T Cells Early in Life
Peter S. Hsu et al.
JOURNAL OF IMMUNOLOGY (2018)
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Anke Fuchs et al.
FRONTIERS IN IMMUNOLOGY (2018)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease
Jun Li et al.
JOURNAL OF IMMUNOLOGY (2015)
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
Joseph G. Crompton et al.
IMMUNOLOGICAL REVIEWS (2014)
Reprogramming antitumor immunity
Joseph G. Crompton et al.
TRENDS IN IMMUNOLOGY (2014)
Lineage relationship of effector and memory T cells
Nicholas P. Restifo et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
CD4 T-cell immunotherapy for chronic viral infections and cancer
Alice O. Kamphorst et al.
IMMUNOTHERAPY (2013)
Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
Ping Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD
Norifumi Sawamukai et al.
BLOOD (2012)
A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells
Wenxian Fu et al.
NATURE IMMUNOLOGY (2012)
Paths to stemness: building the ultimate antitumour T cell
Luca Gattinoni et al.
NATURE REVIEWS CANCER (2012)
Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease
K. L. Hippen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice
Kenrick Semple et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity
Dipica Haribhai et al.
IMMUNITY (2011)
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
Keli L. Hippen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?
Arne N. Akbar et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells
James M. Coghill et al.
BLOOD (2010)
Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update
Corey Cutler et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study
M. Schleuning et al.
BONE MARROW TRANSPLANTATION (2009)
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
James L. Riley et al.
IMMUNITY (2009)
Combined therapy of CD4+CD25+ regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice
Anlun Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Monotherapy rapamycin allows an increase of CD4+ CD25bright+ FoxP3+ T cells in renal recipients
Thijs K. Hendrikx et al.
TRANSPLANT INTERNATIONAL (2009)
Rapamycin Promotes the Enrichment of CD4(+)CD25(hi)FoxP3(+) T Regulatory Cells From Naive CD4(+) T Cells of Baboon That Suppress Antiporcine Xenogenic Response In Vitro
A. K. Singh et al.
TRANSPLANTATION PROCEEDINGS (2009)
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Jochen Huehn et al.
NATURE REVIEWS IMMUNOLOGY (2009)
T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects
Jeffrey A. Bluestone et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
What does the future hold for cell-based tolerogenic therapy?
Jeffrey A. Bluestone et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells
J. J. A. Coenen et al.
BONE MARROW TRANSPLANTATION (2007)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine
E Waldman et al.
BLOOD (2006)
Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice
EL Masteller et al.
JOURNAL OF IMMUNOLOGY (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
PA Taylor et al.
BLOOD (2004)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
分享论文
